ABOUT US
NanoDetection Technology is an early entrant into the diagnostic segment of biochip sensor technology. While the term ‘biochip’ has come to mean many different things, biochips typically combine integrated circuitry and genomic technologies for basic biological research, drug research and disease diagnosis. NanoDetection’s ‘biochip’ is a patented microchip biosensor, based on multiple phototransistor integrated circuits, that detects light (e.g. fluorescence or luminescence) emitted as a result of a chemical reaction caused by DNA hybridization or an antibody/antigen pairing. Unlike historical advances in the diagnostic device sector where new technology simply automates or upgrades conventional methodologies, biochip devices will make obsolete the traditional diagnostic protocol and allow for nearly real-time detection.
As the overwhelming majority of public biochip companies focus on the biological research and drug research market, NanoDetection is one of the first few companies to leverage this technology for diagnostic purposes in veterinary diagnostics, bioterrorism and food safety. NanoDetection’s initial markets enable lower technology development and refinement costs because of easy access to biological samples and lower regulatory hurdles and oversight.
